Article Information
History
- June 30, 2021.
Article Versions
- Version 1 (June 27, 2021 - 13:18).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Vinicius M. Mello1,#,*,
- Cristiane M. Eller2,#,
- Andreza L. Salvio3,#,
- Felipe F. Nascimento3,
- Camila M. Figueiredo3,
- Emanuelle S. R. F. Silva3,
- Paulo S. F. Sousa1,
- Pamela F. Costa3,
- Anne A. P. Paiva4,
- Maria A. M. M. Mares-Guias4,
- Elba R. S. Lemos5 and
- Marco A. P. Horta2,#
- 1Viral Hepatitis Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro RJ 21040-900, Brazil
- 2Biosafety Level 3 Facility (BSL-3), Oswaldo Cruz Foundation, Rio de Janeiro RJ 21040-900, Brazil
- 3COVID-19 Analytical Center, Oswaldo Cruz Foundation, Rio de Janeiro RJ 21040- 900, Brazil
- 4Flavivirus Laboratory, Oswaldo Cruz Institute Oswaldo, Cruz Foundation, Rio de Janeiro RJ 21040-900, Brazil
- 5Hantavirosis and Rickettsiosis Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro RJ 21040-900, Brazil
- ↵*Corresponding author: Vinicius M. Mello, MSc
, Viral Hepatitis Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, 4365 Brazil Avenue, CEP 21040-360, Manguinhos, Rio de Janeiro, Brazil, Phone: +55-21-2562-1946, Email: vmello.fiocruz{at}gmail.com
↵# These authors contributed equally